טוען...
IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells
Dendritic cell (DC) tumor vaccines exert their antitumor effects through the induction of effector T cells. We recently identified Tc9 cells as a new potent antitumor effector T cell subset. However, approaches to direct DCs to preferably prime antitumor Tc9 cells should be further exploited. Here,...
שמור ב:
| הוצא לאור ב: | Cell Mol Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group UK
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6804534/ https://ncbi.nlm.nih.gov/pubmed/30275536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-018-0166-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|